The Surveillance of Hepatocellular Carcinoma

• Conditions: Hepatocellular Carcinoma

• Registration Number: NCT05286099
• Lead Sponsor: Chinese PLA General Hospital

Brief Summary

Early detection of hepatocellular carcinoma is vita to the prognosis of patient. In this study, the occurrence and development of liver cancer were supervised by imaging examination, and the dysplastic nodules will be distinguished from early hepatocellular carcinoma through macro-imaging and micro-pathological features.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-15
• Study First Submitted: 2022-02-22
• Status Verified: 2022-03
• Study First Submitted QC: 2022-03-17
• Last Update Submitted: 2022-03-17
• Study First Posted: 2022-03-18
• Last Update Posted: 2022-03-18
• Primary Completion: 2023-07-01
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients with Hepatitis B and cirrhosis Accept regular imaging examination. Pathological diagnosis of liver cancer.

Exclusion Criteria

• Can't tolerate the enhanced imaging examination Poor medical compliance

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effective detection of early hepatocellular carcinoma	2 years	The occurrence of early hepatocellular carcinoma

Trial Locations

Locations (2)

Chinese PLA General Hospital; 🇨🇳 Beijing, Beijing, China

Chinese PLA general hospital; 🇨🇳 Beijing, China